4501 participants
Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2020-10-01
- Start Date:
- 2010-07-07
- Completion:
- 2020-04-29
Conditions
- Renal Anemia
- Pregnancy
- Lactation
No Results Yet